序号 |
标题 |
次数 |
作者 |
发布时间 |
82846 |
icariside C3,CAS号:108906-48-5 |
149 |
zyl |
2024-11-29 |
82847 |
1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-硝胺基) |
124 |
WYQ |
2024-11-29 |
82848 |
DOTA-tris(acid)-amido-dPEG®11-Maleimide;DOTA-聚乙二醇(dPEG)间隔基-马来酰亚胺 |
115 |
zcy |
2024-11-29 |
82849 |
3-三氟甲基-6-氨基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪类含能化合物 |
95 |
WYQ |
2024-11-29 |
82850 |
DOTA-(Tyr3)-Octreotate ,DOTA-3-酪氨酰基-奥曲肽 |
70 |
wyh |
2024-11-29 |
82851 |
N-(3-(三氟甲基)-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)硝酸酰胺 |
140 |
WYQ |
2024-11-29 |
82852 |
TCO-C3-PEG3-C3-amine,cas:2028288-77-7,反式环辛烯-C3-三聚乙二醇-C3-氨基 |
129 |
zyl |
2024-11-29 |
82853 |
Maleimide-DOTA-GA 马来酰亚胺-DOTA-镓 大环配体化合物 |
178 |
zcy |
2024-11-29 |
82854 |
Mem-Tz-Rh 四嗪与罗丹明结构连接溶酶体靶向探针 |
207 |
WYQ |
2024-11-29 |
82855 |
Mito-Tz-BDP Bodipy与四嗪共轭连接线粒体靶向探针 |
167 |
WYQ |
2024-11-29 |
82856 |
DOTA标记的双c(RGDfK)环肽 |
126 |
wyh |
2024-11-29 |
82857 |
3-三氟甲基-6-硝基胍基 [1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
153 |
WYQ |
2024-11-29 |
82858 |
DOTA-Ubiquicidin (29-41) acetate 基于NOTADOTA定制和偶联 |
121 |
zcy |
2024-11-29 |
82859 |
N-(3-(三氟甲基)-[1,2,4]三唑并[4,3-b] [1,2,4,5]四嗪)硝酸酰胺 |
132 |
WYQ |
2024-11-29 |
82860 |
C16-02:0 PC;CAS号:74389-68-7 |
116 |
zyl |
2024-11-29 |
82861 |
6 -氨-3-(三氟甲基)-[1,2,4]三唑[4,3-b] [1,2,4,5]四嗪 |
102 |
WYQ |
2024-11-29 |
82862 |
Cuprate(2-)-64Cu, [N-[2-[4,10-bis[(carboxy-κO)methyl]-7-(carboxymethyl)-1,4,7,10-tetraazacyclododec-1 定制 |
118 |
zcy |
2024-11-29 |
82863 |
1006711-90-5 ,DOTA-MAL , DOTA-马来酰亚胺 |
157 |
wyh |
2024-11-29 |
82864 |
6 -(3,5-二甲基吡唑)-3-(三氟甲基)-[1,2,4]三唑并[4,3-b] [1,2,4,5]四嗪 |
115 |
WYQ |
2024-11-29 |
82865 |
N-stearoyl-D-erythro-sphingosine (C17 base), powder;CAS号:123065-42-9 |
118 |
zyl |
2024-11-29 |
82866 |
DTPA-BSA-Gd , 二乙三胺五乙酸钆-牛血清白蛋白络合物 |
207 |
wyh |
2024-11-29 |
82867 |
羟基喹啉修饰降冰片烯功能化的聚合物PN2 |
113 |
h |
2024-11-29 |
82868 |
2792156-83-1 IPB-K(DOTA)-FAPI 基于NOTADOTA定制和偶联 |
139 |
zcy |
2024-11-29 |
82869 |
环氧功能化单体插入率的降冰片烯共聚物 aP(BN/MGENB)-x |
147 |
h |
2024-11-29 |
82870 |
萘酰亚胺修饰聚降冰片烯共聚物 P-NB-NA-PEG |
162 |
h |
2024-11-29 |
82871 |
CAS:909024-55-1 DOTA-cyclo(RGDfK)acetate |
90 |
zcy |
2024-11-29 |
82872 |
2192281-54-0 , PSMA IandT |
114 |
wyh |
2024-11-29 |
82873 |
5-降冰片烯-2-甲基-聚环氧丙烷 NB-PPO |
124 |
h |
2024-11-29 |
82874 |
DOTA-PEG(24)-TFP*2TFA 功能性化合物 |
105 |
zcy |
2024-11-29 |
82875 |
N'-(6-(3,5-二甲基吡唑)-1,2,4,5-四嗪)-2,2,2-三氟乙酰肼 |
113 |
WYQ |
2024-11-29 |
82876 |
醚键间隔四咪唑阳离子功能化苯并降冰片二烯单体 BenzoNBD-Bis(Im+Br--Im+I-) |
140 |
h |
2024-11-29 |
82877 |
DOTA-E[c(RGDfK)2] |
129 |
wyh |
2024-11-29 |
82878 |
C18-04:0 PC;CAS号:83526-67-4 |
93 |
zyl |
2024-11-29 |
82879 |
开环易位型聚降冰片烯基醚间隔基柔顺侧链的阴离子交换膜 r PNB-O-Im-x,x=10,20,30和40 |
164 |
h |
2024-11-29 |
82880 |
NOTA-TATE的结构特点 |
108 |
wyh |
2024-11-29 |
82881 |
DOTA(tBu3)-PEG(23)-MAL DOTA(tBu3)-聚乙二醇(23)-马来酰亚胺 |
109 |
zcy |
2024-11-29 |
82882 |
C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z));CAS号:1246304-33-5 |
114 |
zyl |
2024-11-29 |
82883 |
3-(3,5-二甲基吡唑)-6-肼基-1,2,4,5-四嗪 |
141 |
WYQ |
2024-11-29 |
82884 |
功能化的乙烯基加成型降冰片烯嵌段共聚物 aP(NB-O-Br-b-NB-MHE) |
140 |
h |
2024-11-29 |
82885 |
1246303-22-9;Ceramide-1-Phosphate (d18:1/16:0) |
237 |
kx |
2024-11-29 |
82886 |
3-三氟甲基-6-硝基胍基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
180 |
WYQ |
2024-11-29 |
82887 |
6-(3,5-二甲基吡唑)-3-(三氟甲基)-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪 |
95 |
WYQ |
2024-11-29 |
82888 |
降冰片烯-马来酸酐聚合物 BP/THF |
205 |
h |
2024-11-29 |
82889 |
204318-14-9 , 依多曲肽 , DOTA-TOC |
132 |
wyh |
2024-11-29 |
82890 |
四嗪共轭修饰联噻吩荧光骨架(Tz-2-thiophen-3-ylthiophene) |
121 |
WYQ |
2024-11-29 |